SEC Form 4 · accession 0001136261-17-000179
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Sedor
Officer — Chairman of Board and CEO · Director
Period of report
Aug 8, 2017
Accepted (ET)
Aug 9, 2017 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 8, 2017 | A | 10,000 | $0.00 | A | 127,807 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $2.78 | Aug 8, 2017 | A | 30,000 | A | — | Aug 8, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Represents a grant of restricted share units that vest in four equal annual installments of 2,500 shares over a four-year period, with the first installment vesting on August 8, 2018, which is the one-year anniversary of the grant date.
- F2Consists of (x) 30,407 shares of common stock, (y) the unvested amount of previously-awarded restricted share units that vest in two equal installments of 43,700 shares, with the next installment vesting on July 26, 2018 and the final installment vesting on July 26, 2019 and (z) the unvested amount of the restricted share units that vest as described in footnote 1 above.
- F3The stock option vests in four equal annual installments of 7,500 shares over a four-year period, with the first installment vesting at the close of business on August 8, 2018, which is the one-year anniversary of the grant date.